51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti‐Yta

R. Davey,S. Simpkins
DOI: https://doi.org/10.1046/j.1537-2995.1981.21682085759.x
1981-11-12
Transfusion
Abstract:A case is presented in which anti‐Yta produced a moderately accelerated removal of chromium‐labeled Yt(a+) red blood cells (T1/2, 96 hours). Other reported examples of anti‐Yta either have rapidly removed transfused Yt(a+) red blood cells or have permitted apparently normal survival of these cells. In light of this wide variation in in vivo potency of anti‐Yta, it is recommended that chromium red blood cell survival studies be done before transfusion of Yt(a+) red blood cells in sensitized individuals.
What problem does this paper attempt to address?